Abstract:Human neural progenitors are increasingly being employed in drug screens and emerging cell therapies targeted towards neurological disorders where neurogenesis is thought to play a key role including developmental disorders, Alzheimer's disease, and depression. Key to the success of these applications is understanding the mechanisms by which neurons arise. Our understanding of development can provide some guidance but since little is known about the specifics of human neural development and the requirement that cultures be expanded in vitro prior to use, it is unclear whether neural progenitors obey the same developmental mechanisms that exist in vivo. In previous studies we have shown that progenitors derived from fetal cortex can be cultured for many weeks in vitro as undifferentiated neurospheres and then induced to undergo neurogenesis by removing mitogens and exposing them to supportive substrates. Here we use live time lapse imaging and immunocytochemical analysis to show that neural progenitors use developmental mechanisms to generate neurons. Cells with morphologies and marker profiles consistent with radial glia and recently described outer radial glia divide asymmetrically and symmetrically to generate multipolar intermediate progenitors, a portion of which express ASCL1. These multipolar intermediate progenitors subsequently divide symmetrically to produce CTIP2(+) neurons. This 3-cell neurogenic scheme echoes observations in rodents in vivo and in human fetal slice cultures in vitro, providing evidence that hNPCs represent a renewable and robust in vitro assay system to explore mechanisms of human neurogenesis without the continual need for fresh primary human fetal tissue. Knowledge provided by this and future explorations of human neural progenitor neurogenesis will help maximize the safety and efficacy of new stem cell therapies by providing an understanding of how to generate physiologically-relevant cell types that maintain their identities when placed in diagnostic or transplantation environments.

Reversal of Postnatal Brain Astrocytes and Ependymal Cells towards a Progenitor Phenotype in Culture

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Reprogrammed Mouse Astrocytes Retain a “memory” of Tissue Origin and Possess More Tendencies for Neuronal Differentiation Than Reprogrammed Mouse Embryonic Fibroblasts

Transcriptional Mechanisms of Proneural Factors and REST in Regulating Neuronal Reprogramming of Astrocytes.

Decoding single-cell molecular mechanisms in astrocyte-to-iN reprogramming via Ngn2- and Pax6-mediated direct lineage switching

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

Astrocytes adopt a progenitor-like migratory strategy for regeneration in adult brain

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex

Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons

Neonatal cortical astrocytes possess intrinsic potential in neuronal conversion in defined media

Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation.

Stab Wound Injury Elicits Transit Amplifying Progenitor-like Phenotype in Parenchymal Astrocytes

Real time imaging of human progenitor neurogenesis

Unraveling Lineage Roadmaps and Cell Fate Determinants to Postnatal Neural Stem Cells and Ependymal cells in the Developing Ventricular Zone

In vivo chemical reprogramming of astrocytes into neurons

Neurogenic Niche Conversion Strategy Induces Migration and Functional Neuronal Differentiation of Neural Precursor Cells Following Brain Injury

Progress of Reprogramming Astrocytes into Neuron

Challenges and Efficacy of Astrocyte-to-Neuron Reprogramming in Spinal Cord Injury: In Vitro Insights and In Vivo Outcomes

Single-Cell Transcriptome Analyses Reveal Signals to Activate Dormant Neural Stem Cells